Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Safety|September 20, 2007
The use of tacrolimus in the treatment of inflammatory bowel diseaseDorothy K L Chow, Rupert W L LeongBest Practice & Research. Clinical Gastroenterology|March 5, 2009
Non-NSAID non-H. pylori ulcer diseaseDorothy K L Chow, Joseph J Y SungEuropean Journal of Gastroenterology & Hepatology|February 8, 2006
Inter-observer variations on interpretation of capsule endoscopiesLarry H Lai, Grace L H Wong, Dorothy K L Chow, et al.The American Journal of Gastroenterology|June 15, 2006
Long-term follow-up of patients with obscure gastrointestinal bleeding after negative capsule endoscopyLarry H Lai, Grace L H Wong, Dorothy K L Chow, et al.Inflammatory Bowel Diseases|December 11, 2008
Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalizationDorothy K L Chow, Joseph J Y Sung, Justin C Y Wu, et al.Inflammatory Bowel Diseases|December 7, 2007
Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification systemDorothy K L Chow, Rupert W L Leong, Larry H Lai, et al.The American Journal of Gastroenterology|April 1, 2006
Association of intestinal granulomas with smoking, phenotype, and serology in Chinese patients with Crohn's diseaseRupert W L Leong, Ian C Lawrance, Dorothy K L Chow, et al.The American Journal of Gastroenterology|March 6, 2009
Long-term follow-up of ulcerative colitis in the Chinese populationDorothy K L Chow, Rupert W L Leong, Kelvin K F Tsoi, et al.Journal of Gastroenterology and Hepatology|November 22, 2011
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus MelbourneLani Prideaux, Michael A Kamm, Peter De Cruz, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Use of biologics for inflammatory bowel disease in Hong Kong: consensus statementW K Leung, Siew C Ng, Dorothy K L Chow, et al.Pageof 1